October 4, 2018 Immune cells called macrophages that normally clear away the body’s trash don’t do their jobs in lupus. Now, a study of cancer partly funded by the Lupus Research Alliance may explain how these macrophages promote lupus. Douglas Green, PhD, of St. Jude Children’s Research Hospital in Memphis, Tennessee, and colleagues found that […] READ MORE
NEW YORK, NY. Sept. 28 – Congratulations go out to the Lupus Research Alliance advocates! The 2019 spending bill was signed into law today, granting the two requests Lupus Research Alliance advocates made to legislators on “Capitol Hill Day” in March 2018. Approved by Congress earlier in the week, the bill provides $5 million for […] READ MORE
September 25, 2018 Congratulations to Aurinia Pharmaceuticals for completing patient enrollment in the AURORA Phase 3 clinical trial ahead of schedule. The company reported in a press release issued today that due to high patient demand, the target number of patients was surpassed with 358 lupus nephritis (LN) patients enrolled in sites across 27 countries. […] READ MORE
September 20, 2018 Significantly more people are surviving end-stage renal (kidney) disease caused by lupus nephritis according to a long-term analysis published in Arthritis & Rheumatology. The analysis of the national registry of 20,974 patients with end-stage renal disease (ESRD) during the years 1995 through 2014 found that mortality rates significantly declined. In addition, among […] READ MORE
Maybe you can’t run a Marathon…Or have that as a goal for next year. But you can help run lupus into the ground by supporting our Team Life Without Lupus! Team Life Without Lupus is the official competitive team of the Lupus Research Alliance, the largest private funder of lupus research in the world. Through […] READ MORE
September 14, 2018 Congratulations are in order for lupus advocacy! The two budget requests Lupus Research Alliance advocates worked so hard for to fund lupus research were included in the budget appropriations bill released last night by Congress. Last week, the Lupus Research Alliance wrote to the legislators working on final language to request that […] READ MORE
September 7, 2018 We congratulate Dr. Betty Diamond of Feinstein Institute for Medical Research for her recently published work showing that ACE inhibitors, a specific type of hypertension drugs approved for lowering high blood pressure may prevent memory loss for people with lupus. With her 2018 Lupus Insight Prize from the Lupus Research Alliance, Dr. Diamond […] READ MORE
Data from a long-term Black Women’s Health Study of 59,000 Black women found that cigarette smoking raised the risk for lupus, but not significantly compared with those who had never smoked. In contrast, the incidence of lupus was significantly lower among Black women who drank moderately which was defined as greater or equal to four […] READ MORE
Sept. 5, 2018 Our microbiome includes all of the trillions of microorganisms that live in and on us. A recent review article about key discoveries on the role of the microbiome in lupus includes two researchers funded by the Lupus Research Alliance who may have discovered how some of these microbial passengers promote lupus by […] READ MORE
September 4, 2018 The Lupus Research Alliance is disappointed with the results announced by AstraZeneca and MedImmune of the clinical trial testing the investigational drug anifrolumab for moderate to severe systemic lupus erythematosus (SLE). However, the knowledge gained from further analyzing these data will be invaluable in fully understanding the effects of anifrolumab and designing […] READ MORE
August 28, 2018 The Lupus Research Alliance was proud to take part in the NY Jets 2018 KickOff Luncheon that launched the upcoming season while gaining awareness for the worthwhile causes supported by the team. With the help of nearly 800 generous supporters, the luncheon raised over $750,000 to benefit the Lupus Research Alliance along […] READ MORE
August 28, 2018 NEW YORK, NY. Aker BioMarine and Lupus Research Alliance launch a new clinical study, investigating how phospholipid-rich krill oil can benefit people with lupus, with the aim to lessen the severity of symptoms associated with the disease. Affecting an estimated 5 million people worldwide, Systemic Lupus Erythematosus (SLE), better known as lupus, […] READ MORE
because the Lupus Research Alliance board of directors funds all administrative and fundraising costs
